RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Medipal Holdings Stock

Medipal Holdings Revenue 2024

Medipal Holdings Revenue

3.56 T JPY

Ticker

7459.T

ISIN

JP3268950007

WKN

897036

In 2024, Medipal Holdings's sales reached 3.56 T JPY, a 5.91% difference from the 3.36 T JPY sales recorded in the previous year.

The Medipal Holdings Revenue history

YEARREVENUE (undefined JPY)GROSS MARGIN (%)
2027e3.826,46
2026e3.756,58
2025e3.686,70
20243.566,93
20233.366,68
20223.296,61
20213.216,67
20203.257,28
20193.187,31
20183.157,25
20173.067,14
20163.037,18
20152.877,02
20142.957,10
20132.817,19
20122.757,00
20112.667,06
20102.557,51
20092.467,59
20082.258,49
20072.178,68
20061.928,41
20051.678,27

Medipal Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Medipal Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Medipal Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Medipal Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Medipal Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Medipal Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Medipal Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Medipal Holdings’s growth potential.

Medipal Holdings Revenue, EBIT and net profit per share

DateMedipal Holdings RevenueMedipal Holdings EBITMedipal Holdings Net Income
2027e3.82 T undefined0 undefined37 B undefined
2026e3.75 T undefined0 undefined36.04 B undefined
2025e3.68 T undefined0 undefined35.17 B undefined
20243.56 T undefined47.33 B undefined41.47 B undefined
20233.36 T undefined48.97 B undefined38.81 B undefined
20223.29 T undefined45.62 B undefined29.42 B undefined
20213.21 T undefined38.58 B undefined23.93 B undefined
20203.25 T undefined53.11 B undefined37.97 B undefined
20193.18 T undefined49.83 B undefined34.36 B undefined
20183.15 T undefined44.26 B undefined34.78 B undefined
20173.06 T undefined39.65 B undefined29.01 B undefined
20163.03 T undefined42.28 B undefined30.77 B undefined
20152.87 T undefined32.8 B undefined23.69 B undefined
20142.95 T undefined34.66 B undefined25.49 B undefined
20132.81 T undefined28.52 B undefined18.66 B undefined
20122.75 T undefined20.89 B undefined11.65 B undefined
20112.66 T undefined12.59 B undefined1.7 B undefined
20102.55 T undefined18.44 B undefined1.96 B undefined
20092.46 T undefined20.6 B undefined12.51 B undefined
20082.25 T undefined34.95 B undefined27.79 B undefined
20072.17 T undefined33.85 B undefined19.11 B undefined
20061.92 T undefined26.18 B undefined20.41 B undefined
20051.67 T undefined17.62 B undefined8.49 B undefined

Medipal Holdings stock margins

The Medipal Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medipal Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medipal Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Medipal Holdings's sales revenue. A higher gross margin percentage indicates that the Medipal Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Medipal Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Medipal Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Medipal Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Medipal Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Medipal Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Medipal Holdings Margin History

Medipal Holdings Gross marginMedipal Holdings Profit marginMedipal Holdings EBIT marginMedipal Holdings Profit margin
2027e6.93 %0 %0.97 %
2026e6.93 %0 %0.96 %
2025e6.93 %0 %0.95 %
20246.93 %1.33 %1.17 %
20236.68 %1.46 %1.15 %
20226.61 %1.39 %0.89 %
20216.67 %1.2 %0.75 %
20207.28 %1.63 %1.17 %
20197.31 %1.57 %1.08 %
20187.25 %1.41 %1.11 %
20177.14 %1.29 %0.95 %
20167.18 %1.4 %1.02 %
20157.02 %1.14 %0.82 %
20147.1 %1.18 %0.86 %
20137.19 %1.01 %0.66 %
20127 %0.76 %0.42 %
20117.06 %0.47 %0.06 %
20107.51 %0.72 %0.08 %
20097.59 %0.84 %0.51 %
20088.49 %1.55 %1.23 %
20078.68 %1.56 %0.88 %
20068.41 %1.36 %1.06 %
20058.27 %1.06 %0.51 %

Medipal Holdings Aktienanalyse

What does Medipal Holdings do?

Medipal Holdings Corp is a leading Japanese company operating in various areas of the healthcare industry. Founded in 1995, the company has emerged as a key player in the Japanese healthcare sector and beyond. The company operates in different sectors to offer a wide range of products and services. These segments include wholesale and retail distribution of pharmaceuticals and healthcare products, hospital management, pharmaceutical manufacturing and medical technology, as well as pharmaceutical research and development. Medipal Holdings Corp's business model is to provide a complete supply chain in the healthcare industry, ranging from the manufacturing of pharmaceuticals and medical technology to the supply of doctors and hospitals. The company aims to provide a broad range of healthcare products and services that meet the needs of patients and healthcare providers. The pharmaceutical and healthcare products segment has made the company one of the leading distributors in Japan. Medipal Holdings Corp is a key partner for international companies looking to enter the Japanese market. This segment works closely with various medical facilities to ensure the smooth distribution of drugs and products. It also operates a retail chain of pharmacies that focuses on patient consultation. Hospital management is another important segment of Medipal Holdings Corp. The company is a major operator of hospitals in Japan and also operates senior facilities in the country. It is committed to high-quality medical care and improving the patient experience in its facilities. The company has also developed a program for international patients to meet the needs of foreign patients. The manufacturing of pharmaceuticals and medical technology is another important part of Medipal Holdings Corp's business. The company produces generics and also has partnerships with international pharmaceutical companies for the import and distribution of pharmaceutical products. Medipal Holdings Corp also invests in the research and development of new drugs and medical technology. The pharmaceutical research and development segment is one of Medipal Holdings Corp's newest initiatives. The company invests in the research of new drugs and medical technologies to expand its offering of healthcare products and services. It has its own research and development center as well as partnerships with other companies and institutions. In summary, Medipal Holdings Corp is a key player in the Japanese healthcare industry. The company has developed a wide range of healthcare products and services to meet the needs of patients and healthcare providers. It aims to provide a complete supply chain in the healthcare industry, ranging from the manufacturing of pharmaceuticals and medical technology to the supply of doctors and hospitals. Medipal Holdings Corp has a strong position in the pharmaceutical and healthcare products market as well as in hospital management, and is committed to improving the patient experience and researching new healthcare products. Medipal Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Medipal Holdings's Sales Figures

The sales figures of Medipal Holdings originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Medipal Holdings’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Medipal Holdings's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Medipal Holdings’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Medipal Holdings stock

How much revenue did Medipal Holdings generate this year?

Medipal Holdings has achieved a revenue of 3.56 T JPY this year.

How much was the turnover of the company Medipal Holdings compared to the previous year?

The revenue of Medipal Holdings has increased by 5.91% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Medipal Holdings?

The revenue of Medipal Holdings is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Medipal Holdings measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Medipal Holdings so important for investors?

The revenue of Medipal Holdings is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Medipal Holdings pay?

Over the past 12 months, Medipal Holdings paid a dividend of 60 JPY . This corresponds to a dividend yield of about 2.37 %. For the coming 12 months, Medipal Holdings is expected to pay a dividend of 62.18 JPY.

What is the dividend yield of Medipal Holdings?

The current dividend yield of Medipal Holdings is 2.37 %.

When does Medipal Holdings pay dividends?

Medipal Holdings pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Medipal Holdings?

Medipal Holdings paid dividends every year for the past 23 years.

What is the dividend of Medipal Holdings?

For the upcoming 12 months, dividends amounting to 62.18 JPY are expected. This corresponds to a dividend yield of 2.45 %.

In which sector is Medipal Holdings located?

Medipal Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medipal Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medipal Holdings from 12/1/2024 amounting to 30 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Medipal Holdings pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Medipal Holdings in the year 2023?

In the year 2023, Medipal Holdings distributed 53 JPY as dividends.

In which currency does Medipal Holdings pay out the dividend?

The dividends of Medipal Holdings are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medipal Holdings

Our stock analysis for Medipal Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medipal Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.